| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.076 | 0.4 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.05 | 0.4 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.27 | 0.4 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |